Enveric Biosciences, Inc.(ENVB)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

Enveric Biosciences, Inc. (ENVB) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. ENVB is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $48.6m in revenue and is scored on the micro-cap board instead. Top institutional holders of ENVB by reported 13-F value include Sio Capital Management, Ikarian Capital, AdvisorShares Investments, based on the most recent SEC filings. ENVB trades on the Nasdaq exchange and files with the SEC under CIK 890821. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ENVB daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Enveric Biosciences, Inc. directly from SEC EDGAR.

Net Income

$-3.0M

ENVB key financials by period

Enveric Biosciences, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 201910-K/A$39.9M$-5.6M-15.8%
FY 201810-K/A$43.0M$-16.9M-16.6%
FY 201710-K$48.6M$-9.1M-22.4%
FY 201610-K$36.1M$-2.8M-14.9%
FY 201510-K/A$20.3M$-814.1K-3.9%

Institutions holding ENVB

Institutional investors reporting a position in Enveric Biosciences, Inc. on SEC Form 13F.
InstitutionSharesValueReported
Sio Capital Management180,000$248.4K2026-06-30
Ikarian Capital100,002$138.0K2026-06-30
AdvisorShares Investments35,417$48.9K2026-06-30
RENAISSANCE TECHNOLOGIES32,058$44.2K2026-06-30
ARMISTICE CAPITAL32,000$44.2K2026-06-30
BOOTHBAY FUND MANAGEMENT30,142$41.6K2026-06-30
XTX Topco Ltd18,990$26.2K2026-06-30
StoneX Group11,814$21.9K2026-06-30
HRT FINANCIAL15,458$21.0K2026-06-30
VANGUARD CAPITAL MANAGEMENT14,912$20.6K2026-06-30
SEC EDGAR: CIK 890821 →
ENVB

Enveric Biosciences, Inc.

ENVB
NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $48.6M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Net Income

Q2 2026
EDGAR

$-3.03M

EPS (Diluted)

Q2 2026
EDGAR

$-0.76

Top Institutional Holders

as of Q2 2026
$737.7K total
Sio Capital Management, LLC
$248.4KNew
Ikarian Capital, LLC
$138.0KNew
AdvisorShares Investments LLC
$48.9K+108.7%
RENAISSANCE TECHNOLOGIES LLC
$44.2KNew
ARMISTICE CAPITAL, LLC
$44.2KNew
BOOTHBAY FUND MANAGEMENT, LLC
$41.6KNew
XTX Topco Ltd
$26.2KNew
StoneX Group Inc.
$21.9KNew
HRT FINANCIAL LP
$21.0KNew
VANGUARD CAPITAL MANAGEMENT LLC
$20.6KNew

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…